Zynex - 25 Year Stock Price History | ZYXI
Historical daily share price chart and data for Zynex since 2000 adjusted for splits and dividends. The latest closing stock price for Zynex as of August 21, 2025 is 1.53.
- The all-time high Zynex stock closing price was 29583.20 on June 13, 2000.
- The Zynex 52-week high stock price is 9.42, which is 515.7% above the current share price.
- The Zynex 52-week low stock price is 1.23, which is 19.6% below the current share price.
- The average Zynex stock price for the last 52 weeks is 5.39.
| Zynex Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 3.8225 | 7.8100 | 8.3600 | 1.2600 | 1.5300 | -80.90% |
| 2024 | 9.7976 | 10.8900 | 13.7400 | 7.1900 | 8.0100 | -26.45% |
| 2023 | 10.1662 | 13.8800 | 16.8000 | 6.9500 | 10.8900 | -21.71% |
| 2022 | 8.7390 | 8.4015 | 14.2800 | 5.1400 | 13.9100 | 70.88% |
| 2021 | 11.8847 | 11.3327 | 17.7257 | 7.8218 | 8.1403 | -25.93% |
| 2020 | 12.6777 | 6.4665 | 23.3349 | 6.4665 | 10.9898 | 71.03% |
| 2019 | 6.1594 | 2.3596 | 10.2141 | 2.3057 | 6.4257 | 167.69% |
| 2018 | 2.6825 | 2.6240 | 4.2650 | 1.9026 | 2.4004 | -4.78% |
| 2017 | 0.9630 | 0.2759 | 2.5209 | 0.2339 | 2.5209 | 960.09% |
| 2016 | 0.2386 | 0.2933 | 0.3488 | 0.1305 | 0.2378 | -33.78% |
| 2015 | 0.1564 | 0.1427 | 0.3591 | 0.0897 | 0.3591 | 174.54% |
| 2014 | 0.1539 | 0.1469 | 0.2767 | 0.0713 | 0.1308 | -13.38% |
| 2013 | 0.1716 | 0.2652 | 0.2652 | 0.0857 | 0.1510 | -47.11% |
| 2012 | 0.2983 | 0.2856 | 0.3444 | 0.2490 | 0.2855 | 2.88% |
| 2011 | 0.3159 | 0.2530 | 0.4080 | 0.2448 | 0.2775 | 13.36% |
| 2010 | 0.2896 | 0.4325 | 0.4897 | 0.1562 | 0.2448 | -43.40% |
| 2009 | 0.4554 | 0.6284 | 0.7100 | 0.1877 | 0.4325 | -31.62% |
| 2008 | 1.0445 | 0.5345 | 2.5054 | 0.4693 | 0.6325 | 21.10% |
| 2007 | 0.3680 | 0.1061 | 0.6080 | 0.0816 | 0.5223 | 392.27% |
| 2006 | 0.1541 | 0.1632 | 0.2244 | 0.1020 | 0.1061 | -44.68% |
| 2005 | 0.1766 | 0.1224 | 0.3183 | 0.0857 | 0.1918 | 56.70% |
| 2004 | 0.6664 | 0.8161 | 1.5914 | 0.1061 | 0.1224 | -85.00% |
| 2003 | 8.8344 | 20.4022 | 23.6665 | 0.4080 | 0.8161 | -93.33% |
| 2002 | 203.8571 | 244.8260 | 750.8010 | 12.2413 | 12.2413 | -95.71% |
| 2001 | 1273.9600 | 3570.3800 | 3570.3800 | 285.6310 | 285.6310 | -92.53% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.047B | $0.192B |
| Zynex, Inc. engineers, manufactures, markets, and sells medical devices for the electrotherapy, and stroke and spinal cord injury rehabilitation markets primarily in the United States. The company primarily offers electrotherapy products for pain relief and pain management; and NeuroMove for stroke and spinal cord injury rehabilitation. The company's product lines are fully developed, FDA-cleared, commercially sold, and have been developed to uphold the Company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. Zynex markets its products through commissioned and independent sales representatives, as well as directly to end users through advertisements and articles in relevant publications and on the Internet. The company is headquartered in Littleton, Colorado. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $230.506B | 27.03 |
| Boston Scientific (BSX) | United States | $157.140B | 37.47 |
| Stryker (SYK) | United States | $149.815B | 30.50 |
| EssilorLuxottica (ESLOY) | France | $148.753B | 0.00 |
| Medtronic (MDT) | Ireland | $119.490B | 16.86 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.052B | 0.00 |
| Haleon (HLN) | United Kingdom | $44.480B | 25.41 |
| ResMed (RMD) | United States | $42.323B | 30.27 |
| Agilent Technologies (A) | United States | $33.835B | 22.06 |
| GE HealthCare Technologies (GEHC) | United States | $33.726B | 15.85 |
| Terumo (TRUMY) | Japan | $27.731B | 32.86 |
| Koninklijke Philips (PHG) | Netherlands | $26.731B | 17.68 |
| Insulet (PODD) | United States | $23.441B | 78.54 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.941B | 13.33 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.385B | 0.00 |
| Baxter (BAX) | United States | $12.466B | 9.63 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.798B | 28.64 |
| Lantheus Holdings (LNTH) | United States | $3.817B | 10.32 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.443B | 24.09 |
| Perrigo (PRGO) | Ireland | $3.255B | 8.13 |
| Prestige Consumer Healthcare (PBH) | United States | $3.201B | 14.20 |
| ICU Medical (ICUI) | United States | $3.045B | 20.73 |
| Haemonetics (HAE) | United States | $2.623B | 11.71 |
| LeMaitre Vascular (LMAT) | United States | $2.189B | 46.95 |
| AtriCure (ATRC) | United States | $1.793B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.789B | 11.26 |
| Curaleaf Holdings (CURLF) | Canada | $1.750B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.687B | 72.46 |
| AdaptHealth (AHCO) | United States | $1.262B | 17.94 |
| Phibro Animal Health (PAHC) | United States | $1.262B | 16.14 |
| Acuren (TIC) | United States | $1.220B | 0.00 |
| Neogen (NEOG) | United States | $1.210B | 19.21 |
| BioLife Solutions (BLFS) | United States | $1.196B | 2496.00 |
| Tilray Brands (TLRY) | Canada | $1.167B | 0.00 |
| Valneva SE (VALN) | France | $0.979B | 0.00 |
| InMode (INMD) | Israel | $0.897B | 8.30 |
| Kestra Medical Technologies (KMTS) | United States | $0.852B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.626B | 0.00 |
| SNDL (SNDL) | Canada | $0.581B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.557B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.535B | 0.00 |
| ZimVie (ZIMV) | United States | $0.535B | 20.61 |
| Surmodics (SRDX) | United States | $0.528B | 0.00 |
| Evolus (EOLS) | United States | $0.468B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.466B | 16.04 |
| CeriBell (CBLL) | United States | $0.425B | 0.00 |
| Owens & Minor (OMI) | United States | $0.412B | 3.66 |
| Sanuwave Health (SNWV) | United States | $0.338B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.328B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.303B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.290B | 0.00 |
| Omeros (OMER) | United States | $0.285B | 0.00 |
| Brainsway (BWAY) | Israel | $0.279B | 56.81 |
| Sanara MedTech (SMTI) | United States | $0.274B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.266B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.266B | 20.18 |
| High Tide (HITI) | Canada | $0.250B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.238B | 0.00 |
| Quanterix (QTRX) | United States | $0.228B | 0.00 |
| Cerus (CERS) | United States | $0.222B | 0.00 |
| Exagen (XGN) | United States | $0.217B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.212B | 0.00 |
| Organigram Global (OGI) | Canada | $0.201B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.194B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.185B | 15.47 |
| FitLife Brands (FTLF) | United States | $0.157B | 19.34 |
| Biote (BTMD) | United States | $0.147B | 4.87 |
| Jushi Holdings (JUSHF) | United States | $0.125B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.098B | 0.00 |
| MacroGenics (MGNX) | United States | $0.094B | 0.00 |
| Fonar (FONR) | United States | $0.094B | 12.10 |
| Jin Medical (ZJYL) | China | $0.089B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.085B | 0.00 |
| Apyx Medical (APYX) | United States | $0.077B | 0.00 |
| Safety Shot (SHOT) | United States | $0.070B | 0.00 |
| Agape ATP (ATPC) | $0.065B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.056B | 0.00 |
| ImmuCell (ICCC) | United States | $0.055B | 31.80 |
| Veru (VERU) | United States | $0.052B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 34.00 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 14.21 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.031B | 0.00 |
| Senestech (SNES) | United States | $0.023B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Allurion Technologies (ALUR) | United States | $0.016B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.008B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |